Heterocyclic compound and organic electroluminescent device thereof
By using heterocyclic compounds as electron transport materials and N-type charge generation layers in organic electroluminescent devices, the problem of electron and hole transport imbalance is solved, and the luminous efficiency and lifetime of the device are improved.
Patent Information
- Application Number
- CN202410946378.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-15
- Publication Date
- 2024-11-08
AI Technical Summary
In existing organic electroluminescent devices, electron transport materials have problems such as low electron mobility and mismatch in energy levels, resulting in imbalance in electron and hole transmission and affecting device performance.
A heterocyclic compound is used as an electron transport material and an N-type charge generation layer material. Through its good thermal stability and electron transport ability, it effectively blocks hole diffusion and improves the electron and hole recombination efficiency in the luminescent layer.
The drive voltage of the device is reduced, the luminous efficiency and service life are improved, and the overall performance of the device is enhanced.
Smart Images

Figure BDA0004945824130000011 
Figure BDA0004945824130000021 
Figure BDA0004945824130000022
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic electroluminescent materials, and in particular to a heterocyclic compound and an organic electroluminescent device thereof. Background Art
[0002] Organic Light-Emitting Diode (OLED), also known as organic light-emitting diode, has attracted widespread attention due to its advantages such as light weight, fast response speed, high resolution, good color purity and low power consumption, and has been applied to many fields such as lighting, display, and planar light sources.
[0003] The light-emitting principle of organic electroluminescent devices is that under the action of an external electric field, electrons and holes are injected from the cathode and anode respectively, and enter the light-emitting layer through the hole transport region and the electron transport region. The electrons and holes recombine to produce excitons, and the excitons undergo radiation decay and emit light. The hole transport region includes the hole injection layer, the hole transport layer, the electron blocking layer, etc.; the electron transport region includes the electron injection layer, the electron transport layer, the hole blocking layer, etc. However, the electron transport materials currently used have problems such as low electron mobility and energy level mismatch, which leads to increased electron injection potential, unbalanced electron and hole transport in the device, and hole diffusion to one side of the electron transport layer, which seriously affects the performance of the device.
[0004] In order to further improve the performance of organic electroluminescent devices, a stacked organic electroluminescent device can be used, that is, two or more light-emitting layer stacks are arranged between the cathode and the anode, and the charge generation layer is used to connect them in series. Under the action of an external electric field, the electrons and holes generated by the charge generation layer are respectively injected into the adjacent light-emitting units, and are compounded into excitons in the light-emitting units to emit light. Therefore, the selection and design of the charge generation layer material are key factors affecting the performance of the stacked organic electroluminescent device. The charge generation layer can be divided into an N-type charge generation layer and a P-type charge generation layer. Among them, the N-type charge generation layer material not only needs to have a strong ability to generate electrons under an external electric field, but also needs to have a matching energy level with the adjacent organic functional layer to facilitate the effective transmission of electrons and maintain the charge balance inside the device, thereby improving the performance of the stacked organic electroluminescent device. At present, many N-type charge generation layer materials still have problems such as insufficient electron transmission capacity and unsatisfactory electron tolerance and film stability, resulting in a decrease in the performance of the stacked organic electroluminescent device.
[0005] In summary, it is necessary to develop and design electron transport materials, hole blocking materials and N-type charge generation layer materials with excellent performance to improve the problems existing in organic electroluminescent devices, thereby improving the performance of organic electroluminescent devices. Summary of the invention
[0006] In view of the problems existing in the prior art, the present invention provides a heterocyclic compound and an organic electroluminescent device thereof.
[0007] The present invention provides a heterocyclic compound represented by the following formula 1:
[0008]
[0009] Wherein, the x is the same or different and is selected from CR c or N, and at least one x is selected from N, at most three x are selected from N, and the x bonded to L0, L1, L2 is selected from C atoms;
[0010] The R c One selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring;
[0011] The Ar1 is selected from the group shown in the following formula 1-a or formula 1-b,
[0012]
[0013] The Y is selected from O or S; the z is the same or different and is selected from CR0 or N, and the z bonded to L1 is selected from C atom;
[0014] The R0 is selected from one of hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0015] The R1 is selected from one of hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0016] The R a , R bthe same or different selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring; the "substituted or unsubstituted C2-C30 heteroaryl" is selected from substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted triazine, substituted or unsubstituted quinolyl, substituted or unsubstituted isoquinolyl, substituted or unsubstituted quinazolinyl, substituted or unsubstituted quinoxalinyl, substituted or unsubstituted o-phenanthroline, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted benzoxazolyl, substituted or unsubstituted benzothiazolyl; or said R a , R b The corresponding C atom is the connection site with L2, or the adjacent R a , R b Bonded to form one of the following alicyclic or spirocyclic structures,
[0017]
[0018] The R q The same or different ones are selected from hydrogen, deuterium, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring;
[0019] The R2 and R3 are the same or different and are selected from one of hydrogen, deuterium, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring, or two adjacent R3 are bonded to form a substituted or unsubstituted ring; the "substituted or unsubstituted" substituent is selected from one of hydrogen, deuterium, halogen, C1-C30 alkyl, C3-C30 cycloalkyl, C6-C30 aryl, C2-C30 heteroaryl, C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring;
[0020] The n1 is selected from 0, 1, 2 or 3; the n2 is selected from 0, 1, 2, 3 or 4;
[0021] The q1 is selected from 0, 1, 2, 3 or 4; the q2 is selected from 0, 1, 2, 3, 4, 5 or 6; the q3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the q4 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; the q5 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12; the q6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14; the q7 is selected from 0, 1 or 2;
[0022] The Ar is selected from one of the formula 1-a, formula 1-b or the groups shown below,
[0023]
[0024] The v is the same or different from CR d or N, and v bonded to L0 is selected from C atoms;
[0025] The W is selected from O, S, CR f R g or NR h ;
[0026] The R d the same or different selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or two adjacent R d Bonding to form substituted or unsubstituted alicyclic or aromatic rings;
[0027] The R f , R g The same or different R is selected from hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or adjacent R f , R g Bonding to form a substituted or unsubstituted ring;
[0028] The R hOne selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0029] The L2 is selected from one or a combination of the following groups d-1 to d-6,
[0030]
[0031] The t is the same or different from CR i or N;
[0032] The Q1 is selected from O, S, CR j R k or NR m ; Q2 is selected from O or S;
[0033] The R i The same or different R is selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or two adjacent R i Bonding to form a substituted or unsubstituted ring;
[0034] The R j , R k The same or different R is selected from hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or adjacent R j , R k Bonding to form a substituted or unsubstituted ring;
[0035] The R m One selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0036] The L0 and L1 are the same or different and are selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring fused sub-group;
[0037] The "substituted or unsubstituted" substituent group in L0 and L1 is selected from one of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, and a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring.
[0038] The condition is that the R a , R b When the corresponding C atom is the connection site with L2, the case where L2 is selected from the group shown in d-1 is excluded.
[0039] In addition, the present invention further provides an organic electroluminescent device, which includes a first electrode; a second electrode arranged opposite to the first electrode; and an organic layer arranged between the first electrode and the second electrode, wherein the organic layer contains the heterocyclic compound described in the present invention.
[0040] Beneficial effects: The heterocyclic compound of formula 1 of the present invention has good thermal stability, good electron transport ability and suitable energy level. When used as an electron transport material in an organic electroluminescent device, it is not only beneficial to the injection and transport of electrons in the device, but also can effectively block the diffusion of holes to the electron transport layer, improve the recombination efficiency of electrons and holes in the light-emitting layer, and further improve the performance of the organic electroluminescent device. Specifically, it reduces the driving voltage of the device, improves the luminous efficiency of the device, and prolongs the service life of the device.
[0041] In addition, the heterocyclic compound of the present invention has good electron generation ability and high electron mobility. When used as an N-type charge generation layer material in an organic electroluminescent device, it can effectively balance the charge inside the device, reduce the driving voltage of the device, improve the luminous efficiency of the device, and extend the service life of the device. DETAILED DESCRIPTION
[0042] The present invention is further explained below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention. After reading the present invention, various equivalent forms of modifications to the present invention by those skilled in the art all fall within the scope of protection required by this application.
[0043] In the compounds of the present invention, any atom not designated as a particular isotope includes any stable isotope of that atom, and includes the atom in both its natural isotopic abundance and unnatural abundance.
[0044] The halogen described in the present invention includes fluorine, chlorine, bromine and iodine.
[0045] In the present invention, the "unsubstituted ZZ group" in the "substituted or unsubstituted ZZ group" means that the hydrogen atom of the "ZZ group" is not replaced by a substituent. For example, the "unsubstituted aryl group" in the "substituted or unsubstituted C6-C30 aryl group" means that the hydrogen atom of the "aryl group" is not replaced by a substituent. And so on.
[0046] In the present invention, "CXX-CYY" in "substituted or unsubstituted ZZ group of CXX-CYY" represents the number of carbon atoms in the unsubstituted "ZZ group", and when the "ZZ group" has a substituent, the number of carbon atoms of the substituent is not included. For example, "C6-C30" in "substituted or unsubstituted C6-C30 aryl group" represents the number of carbon atoms in the unsubstituted "aryl group", and when the "aryl group" has a substituent, the number of carbon atoms in the substituent is not included. "C3-C30" in "substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring group" represents the number of carbon atoms in the unsubstituted "alicyclic ring", and when the "alicyclic ring" has a substituent, the number of carbon atoms of the substituent is not included; "C6-C30" represents the number of carbon atoms in the unsubstituted "aromatic ring", and when the "aromatic ring" has a substituent, the number of carbon atoms of the substituent is not included. And so on.
[0047] In the present invention, when the position of a substituent on a ring is not fixed, it means that it can be attached to any of the corresponding optional positions of the ring.
[0048] For example, Can be expressed Can be expressed Can be expressed And so on.
[0049] In this specification, when a substituent or a bond at a connection site runs through two or more rings, it indicates that it can be connected to any of the two or more rings, specifically, it can be connected to any of the corresponding optional sites of the ring. For example, Can be expressed Can be expressed And so on.
[0050] In the present invention, "two adjacent groups are bonded to form a ring" means that adjacent groups are bonded to each other and optionally aromatized to form a substituted or unsubstituted hydrocarbon ring or a substituted or unsubstituted heterocycle. The hydrocarbon ring may be an aliphatic hydrocarbon ring or an aromatic hydrocarbon ring. The heterocycle may include an aliphatic heterocycle or an aromatic heterocycle. The aliphatic hydrocarbon ring may be a saturated aliphatic hydrocarbon ring or an unsaturated aliphatic hydrocarbon ring, and the aliphatic heterocycle may be a saturated aliphatic heterocycle or an unsaturated aliphatic heterocycle. The hydrocarbon ring and the heterocycle may be monocyclic or polycyclic groups. Examples are shown below:
[0051]
[0052] In addition, the ring formed by the combination of adjacent groups can be connected to another ring to form a spiro structure. For example:
[0053]
[0054] In the present invention, the ring formed by connection can be a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring, a condensed ring, a spiro ring, etc., for example, cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclopentene, cyclohexene, benzene, naphthalene, phenanthrene, triphenylene, pyridine, pyrimidine, quinoline, isoquinoline, quinazoline, quinoxaline, fluorene, dibenzofuran, dibenzothiophene, carbazole, etc., but are not limited thereto.
[0055] The term "substituted" in "substituted or unsubstituted" as used herein means that at least one hydrogen atom on the group is replaced by a substituent. When multiple hydrogen atoms are replaced by multiple substituents, the multiple substituents may be the same or different. The position of the hydrogen atoms replaced by the substituents may be any position. The substituent represented by the "substituted" in the above-mentioned "substituted or unsubstituted" includes the following groups, deuterium, tritium, cyano, halogen, nitro, substituted or unsubstituted silyl, substituted or unsubstituted C1~C15 alkoxy, substituted or unsubstituted C6~C20 aryloxy, substituted or unsubstituted C2~C15 heterocyclic group, substituted or unsubstituted C1~C15 alkyl, substituted or unsubstituted C3~C15 cycloalkyl, substituted or unsubstituted C6~C20 aryl, substituted or unsubstituted C2~C20 heteroaryl, substituted or unsubstituted C3~C15 alicyclic and C6~C20 aromatic ring fused ring group, substituted or unsubstituted C3~C15 alicyclic and C2~C20 heteroaromatic ring fused ring group, etc. Preferred are the following groups: deuterium, tritium, cyano, halogen, nitro, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, bornyl, isobornyl, fencyl, silyl, trimethylsilyl, triethylsilyl, triphenylsilyl, phenyl, biphenyl, naphthyl, phenanthrenyl, triphenylene, anthracenyl, pyrenyl, , benzothiophene, dibenzothiophene, indolyl, carbazolyl, pyridyl, pyrimidyl, pyrazinyl, pyridazinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, etc. In addition, each of the above substituents can be substituted or unsubstituted. Two adjacent substituents can be bonded to form a ring.
[0056] The alkyl group described in the present invention refers to a hydrocarbon group formed by removing a hydrogen atom from an alkane molecule. The alkyl group may be a straight-chain alkyl group or a branched-chain alkyl group. When the number of carbon atoms of the chain alkyl group described in the present invention is three or more, its isomers are included, for example, the propyl group includes n-propyl and isopropyl; the butyl group includes n-butyl, isobutyl, sec-butyl, tert-butyl, and so on. Examples of the alkyl group include, but are not limited to, the groups described below, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, etc., but are not limited thereto. The number of carbon atoms of the alkyl group is C1 to C30, preferably C1 to C25, preferably C1 to C20, preferably C1 to C15, and more preferably C1 to C10.
[0057] The silyl group described in the present invention refers to -Si(R k )3 groups, wherein each R k The same or different groups are selected from the following groups: hydrogen, deuterium, tritium, cyano, halogen, nitro, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C1-C30 alkenyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C60 aryl, substituted or unsubstituted C2-C60 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C60 aromatic fused ring, substituted or unsubstituted C3-C30 alicyclic and C2-C60 heteroaromatic fused ring. Preferably, each R k The same or different groups are selected from the following groups: hydrogen, deuterium, tritium, cyano, halogen, nitro, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C3-C30 cycloalkyl. The carbon number of the alkyl group is preferably C1-C20, preferably C1-C15, more preferably C1-C10, and most preferably C1-C8. The carbon number of the cycloalkyl group is preferably C3-C20, preferably C3-C15, more preferably C3-C10, and most preferably C3-C7. Preferably, each R kThe same or different radicals are selected from the following groups: hydrogen, deuterium, tritium, cyano, halogen, nitro, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted propyl, substituted or unsubstituted butyl, substituted or unsubstituted pentyl, substituted or unsubstituted hexyl, substituted or unsubstituted heptyl, substituted or unsubstituted octyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cycloheptyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted naphthyl. Preferred substituted silyl groups specifically include trimethylsilyl, triethylsilyl, triisopropylsilyl, tert-butyldimethylsilyl, vinyldimethylsilyl, propyldimethylsilyl, triphenylsilyl, diphenylsilyl, phenylsilyl and the like, but are not limited thereto.
[0058] The cycloalkyl group of the present invention refers to a hydrocarbon group formed by removing a hydrogen atom from a cycloalkane molecule. The cycloalkyl group includes a monocyclic cycloalkyl group, a polycyclic cycloalkyl group, and a bridged ring cycloalkyl group. Examples of the cycloalkyl group include, but are not limited to, the following groups, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, adamantyl, norbornyl, bornyl, fenchyl, isobornyl, etc., but are not limited thereto. The number of carbon atoms of the cycloalkyl group is C3 to C30, preferably C3 to C25, preferably C3 to C20, preferably C3 to C15, and more preferably C3 to C10.
[0059] The aryl group described in the present invention refers to a general term for a monovalent group remaining after removing a hydrogen atom from the aromatic carbon of an aromatic compound molecule. The aryl group includes a monocyclic aryl group, a polycyclic aryl group, a condensed ring aryl group or a combination thereof. Examples of the aryl group include, but are not limited to, the following groups: phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracenyl, triphenylene, fluorenyl, benzofluorenyl, spirobifluorenyl, spiroanthrafluorenyl, pyrenyl, The number of carbon atoms in the aryl group is C6 to C30, preferably C6 to C25, and more preferably C6 to C20.
[0060] The heteroaryl group of the present invention refers to a monovalent group in which at least one carbon atom in the aromatic group is replaced by a heteroatom, wherein the heteroatom is selected from O, S, N, Si, B, P, etc., but is not limited thereto. Examples of the heteroaryl group include, but are not limited to, benzofuranyl, naphthofuranyl, phenanthrofuranyl, dibenzofuranyl, benzodibenzofuranyl, benzothiophenyl, naphthiophenyl, phenanthrothiophenyl, dibenzothiophenyl, benzodibenzothiophenyl, indolyl, naphthoindolyl, carbazolyl, benzocarbazolyl, spirofluoreneoxanthracene, spirofluorenethioanthracene, spirofluoreneazaanthracenyl, spirofluorenesilanthracene, benzodioxolyl, benzodisulfide, dihydroisobenzofuranyl, dihydrobenzofuranyl, dihydrobenzothiophenyl, dihydroisobenzothiophenyl, phenoxazinyl, phenothiazinyl, dihydroacridinyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, etc., but are not limited thereto. The carbon number of the heteroaryl group may be C2 to C30, preferably C2 to C25, and more preferably C3 to C20.
[0061] The fused ring group of alicyclic ring and aromatic ring described in the present invention refers to the general term for a monovalent group after alicyclic ring and aromatic ring are fused together and one hydrogen atom is removed. Examples of the fused ring group of alicyclic ring and aromatic ring include, but are not limited to, the following groups, benzocyclopropane, benzocyclobutane, benzocyclobutenyl, dihydroindenyl, indenyl, tetrahydronaphthyl, dihydronaphthyl, benzocycloheptane, benzocycloheptenyl, etc., but are not limited thereto. The carbon number of the alicyclic ring is C3-C30, preferably C3-C20, preferably C3-C15, more preferably C3-C10, and more preferably C3-C8. The carbon number of the aromatic ring is C6-C30, preferably C6-C25, preferably C6-C18, more preferably C6-C12, and more preferably C6-C10.
[0062] The arylene group described in the present invention refers to the general term for the divalent group left after two hydrogen atoms are removed from the aromatic carbon of the aromatic compound molecule. The arylene group includes a monocyclic arylene group, a polycyclic arylene group, a condensed ring arylene group or a combination thereof. Examples of the arylene group include, but are not limited to, the following groups, phenylene, biphenylene, terphenylene, naphthylene, phenanthrenyl, fluorenylene, benzofluorenylene, dibenzofluorenylene, naphthylene, spirobifluorenylene, etc., but are not limited thereto. The number of carbon atoms of the arylene group is C6 to C30, preferably C6 to C25, preferably C6 to C20, and more preferably C6 to C18.
[0063] The heteroarylene group described in the present invention refers to a divalent group in which at least one carbon atom in the arylene group is replaced by a heteroatom. The heteroatom is selected from O, S, N, Si, B, P, etc., but is not limited thereto. The heteroarylene group includes a monocyclic heteroarylene group, a polycyclic heteroarylene group, a condensed ring heteroarylene group, or a combination thereof. Examples of the heteroarylene group include, but are not limited to, the following groups, pyridylene, pyrimidylene, pyrazinylene, pyridazinylene, triazinylene, quinolylene, quinazolinylene, naphthyridinylene, etc., but are not limited thereto. The number of carbon atoms in the heteroarylene group is C2 to C30, preferably C2 to C25, and preferably C2 to C20.
[0064] The sub-fused ring group of the alicyclic ring and the aromatic ring described in the present invention refers to the general term for the divalent group left after the alicyclic ring and the aromatic ring are fused together and two hydrogen atoms are removed. The sub-fused ring of the alicyclic ring and the aromatic ring includes dihydroindenyl, indenyl, tetrahydronaphthyl, dihydronaphthyl, benzocyclopropane, benzocyclobutane, benzocycloheptane, benzocyclobutenyl, naphthocyclopentane, etc., but is not limited thereto. The number of carbon atoms of the alicyclic ring is 3 to 30, preferably 3 to 20, and more preferably 3 to 10. The number of carbon atoms of the aromatic ring is 6 to 30, preferably 6 to 25, preferably 6 to 18, and more preferably 6 to 10.
[0065] The present invention provides a heterocyclic compound represented by the following formula 1:
[0066]
[0067] Wherein, the x is the same or different and is selected from CR c or N, and at least one x is selected from N, at most three x are selected from N, and the x bonded to L0, L1, L2 is selected from C atoms;
[0068] The R c One selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring;
[0069] The Ar1 is selected from the group shown in the following formula 1-a or formula 1-b,
[0070]
[0071] The Y is selected from O or S; the z is the same or different and is selected from CR0 or N, and the z bonded to L1 is selected from C atom;
[0072] The R0 is selected from one of hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0073] The R1 is selected from one of hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0074] The R a , R b the same or different selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring; the "substituted or unsubstituted C2-C30 heteroaryl" is selected from substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted triazine, substituted or unsubstituted quinolyl, substituted or unsubstituted isoquinolyl, substituted or unsubstituted quinazolinyl, substituted or unsubstituted quinoxalinyl, substituted or unsubstituted o-phenanthroline, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted benzoxazolyl, substituted or unsubstituted benzothiazolyl; or said R a , R b The corresponding C atom is the connection site with L2, or the adjacent R a , R b Bonded to form one of the following alicyclic or spirocyclic structures,
[0075]
[0076] The R q The same or different ones are selected from hydrogen, deuterium, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring;
[0077] The R2 and R3 are the same or different and are selected from one of hydrogen, deuterium, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring, or two adjacent R3 are bonded to form a substituted or unsubstituted ring; the "substituted or unsubstituted" substituent is selected from one of hydrogen, deuterium, halogen, C1-C30 alkyl, C3-C30 cycloalkyl, C6-C30 aryl, C2-C30 heteroaryl, C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring;
[0078] The n1 is selected from 0, 1, 2 or 3; the n2 is selected from 0, 1, 2, 3 or 4;
[0079] The q1 is selected from 0, 1, 2, 3 or 4; the q2 is selected from 0, 1, 2, 3, 4, 5 or 6; the q3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the q4 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; the q5 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12; the q6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14; the q7 is selected from 0, 1 or 2;
[0080] The Ar is selected from one of the formula 1-a, formula 1-b or the groups shown below,
[0081]
[0082] The v is the same or different from CR d or N, and v bonded to L0 is selected from C atoms;
[0083] The W is selected from O, S, CR f R g or NR h ;
[0084] The R d the same or different selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or two adjacent R d Bonding to form substituted or unsubstituted alicyclic or aromatic rings;
[0085] The R f, R g The same or different R is selected from hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or adjacent R f , R g Bonding to form a substituted or unsubstituted ring;
[0086] The R h One selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0087] The L2 is selected from one or a combination of the following groups d-1 to d-6,
[0088]
[0089] The t is the same or different from CR i or N;
[0090] The Q1 is selected from O, S, CR j R k or NR m ; Q2 is selected from O or S;
[0091] The R i The same or different R is selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or two adjacent R i Bonding to form a substituted or unsubstituted ring;
[0092] The R j , R k The same or different R is selected from hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or adjacent R j , R kBonding to form a substituted or unsubstituted ring;
[0093] The R m One selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring;
[0094] The L0 and L1 are the same or different and are selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring fused sub-group;
[0095] The "substituted or unsubstituted" substituent group in L0 and L1 is selected from one of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, and substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring;
[0096] The condition is that the R a , R b When the corresponding C atom is the connection site with L2, the case where L2 is selected from the group shown in d-1 is excluded.
[0097] Preferably, the One selected from the following groups,
[0098]
[0099] The R c selected from hydrogen, deuterium, cyano, halogen or substituted or unsubstituted one of the following groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, trimethyl ... tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0100] The t1 is selected from 0, 1 or 2; the t2 is selected from 0 or 1.
[0101] Preferably, the One selected from the following groups,
[0102]
[0103] The R c selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuteriums: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropanyl, benzocyclobutanyl, benzocyclopentanyl, benzocyclohexanyl, benzocycloheptyl, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0104] The t1 is selected from 0, 1 or 2.
[0105] Preferably, Ar1 is selected from the group shown in Formula 1-b.
[0106] Preferably, Ar is selected from the group shown in Formula 1-b.
[0107] More preferably, Ar1 and Ar are selected from the group shown in Formula 1-b.
[0108] Preferably, the formula 1-a is selected from one of the following groups:
[0109]
[0110] The formula 1-b is selected from one of the following groups:
[0111]
[0112] Said Y is selected from O or S;
[0113] The R0 is selected from hydrogen, deuterium or a substituted or unsubstituted group as shown below: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tritert-butyl, ... Butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0114] The R1 is selected from hydrogen, deuterium or a substituted or unsubstituted group as shown below: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tritert-butyl, ... Butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0115] The m1 is selected from 0, 1, 2 or 3; the m2 is selected from 0, 1 or 2; the m3 is selected from 0 or 1; and the m4 is selected from 0, 1, 2, 3 or 4.
[0116] Preferably, R0 is selected from hydrogen, deuterium, or one of the following groups which are substituted or unsubstituted by one or more deuteriums or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, trimethyl ... Isopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl.
[0117] Preferably, R1 is selected from hydrogen, deuterium, or one of the following groups which are substituted or unsubstituted by one or more deuteriums or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, trimethyl ... Isopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl.
[0118] Preferably, the One selected from the following groups,
[0119]
[0120]
[0121] The R4 and R5 are the same or different and are selected from hydrogen, deuterium or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl , triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0122] The R2 and R3 are the same or different and are selected from hydrogen, deuterium, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, or two adjacent R3 may be bonded to each other to form a substituted or unsubstituted ring;
[0123] The R q the same or different ones are selected from one or a combination of hydrogen, deuterium, tritium, halogen, methyl, ethyl, propyl, butyl, trifluoromethyl, isopropyl, cyclopropyl, tert-butyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, trimethylsilyl, triethylsilyl, triphenylsilyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthryl, triphenylene, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0124] The q1 is selected from 0, 1, 2, 3 or 4; the q2 is selected from 0, 1, 2, 3, 4, 5 or 6; the q3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the q4 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; the q6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14;
[0125] The n1 is selected from 0, 1, 2 or 3; the n2 is selected from 0, 1, 2, 3 or 4; the n3 is selected from 0, 1, 2, 3, 4 or 5; the n4 is selected from 0, 1, 2, 3, 4, 5, 6 or 7; and n5 is selected from 0, 1, 2, 3, 4, 5 or 6.
[0126] Preferably, Ar is selected from one of Formula 1-a, Formula 1-b or the groups shown below,
[0127]
[0128] The W is selected from O, S, CR f R g or NR h ;
[0129] The R dthe same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups substituted or unsubstituted by one or more deuterium, C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl alkyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, dibenzofuranyl, dibenzothienyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, or two adjacent R d Bonding to form substituted or unsubstituted benzene rings;
[0130] The R f , R g The same or different ones are selected from hydrogen, deuterium or one or more deuterium, C1-C6 alkyl substituted or unsubstituted one of the following groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylmethyl Silyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, or an adjacent R f , R g Bonding to form a substituted or unsubstituted ring;
[0131] The R hOne of the following groups substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilane yl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0132] The R e the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuteriums or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0133] The p1 is selected from 0, 1, 2, 3, 4 or 5; the p2 is selected from 0, 1, 2, 3 or 4; the p3 is selected from 0, 1, 2 or 3; the p4 is selected from 0, 1, 2, 3, 4, 5, 6 or 7; the p5 is selected from 0, 1, 2, 3, 4, 5 or 6; the p6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8 or 9; the p7 is selected from 0, 1 or 2; the p8 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the p9 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11.
[0134] Preferably, Ar is selected from one of Formula 1-a, Formula 1-b or the groups shown below,
[0135]
[0136]
[0137] The R dthe same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, or two adjacent R d Bonding to form substituted or unsubstituted benzene rings;
[0138] The R f , R g The same or different ones are selected from one of hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthryl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazinyl, quinolyl, isoquinolyl, quinazolinyl, and quinoxalinyl;
[0139] The R h One selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthryl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl;
[0140] The R eThe same or different ones are selected from one of hydrogen, deuterium, cyano, halogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, and quinoxalinyl;
[0141] The p1 is selected from 0, 1, 2, 3, 4 or 5; the p2 is selected from 0, 1, 2, 3 or 4; the p3 is selected from 0, 1, 2 or 3; the p4 is selected from 0, 1, 2, 3, 4, 5, 6 or 7; p5 is selected from 0, 1, 2, 3, 4, 5 or 6; p6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8 or 9; the p7 is selected from 0, 1 or 2; the p8 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8.
[0142] Most preferably, Ar is selected from the group shown in Formula 1-b.
[0143] Preferably, L2 is selected from one or a combination of the following groups:
[0144]
[0145] The R i the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, or two adjacent R i Bonding to form a substituted or unsubstituted ring;
[0146] The R j , R kThe same or different ones are selected from hydrogen, deuterium or one or more deuterium, C1-C6 alkyl substituted or unsubstituted one of the following groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilane one of benzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl and quinoxalinyl;
[0147] The R m One of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthryl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, and quinoxalinyl;
[0148] The R s The same or different ones are selected from one or a combination of hydrogen, deuterium, cyano, halogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, and quinoxalinyl;
[0149] The c1 is selected from 0, 1, 2, 3 or 4; the c2 is selected from 0, 1, 2, 3, 4, 5 or 6; the c3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the c4 is selected from 0, 1, 2 or 3; the c5 is selected from 0, 1 or 2; the c6 is selected from 0 or 1; the c7 is selected from 0, 1, 2, 3, 4 or 5;
[0150] The s1 is selected from 0, 1 or 2; the s2 is selected from 0, 1, 2, 3 or 4; the s3 is selected from 0, 1, 2, 3, 4, 5 or 6; the s4 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8.
[0151] Preferably, the combination is selected from one of the following groups:
[0152]
[0153] The R i the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, or two adjacent R i Bonding to form a substituted or unsubstituted ring;
[0154] The R s The same or different ones are selected from one or a combination of hydrogen, deuterium, cyano, halogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, and quinoxalinyl;
[0155] The c1 is selected from 0, 1, 2, 3 or 4; the c4 is selected from 0, 1, 2 or 3; the c5 is selected from 0, 1 or 2; the c7 is selected from 0, 1, 2, 3, 4 or 5;
[0156] The s1 is selected from 0, 1 or 2; the s2 is selected from 0, 1, 2, 3 or 4; the s3 is selected from 0, 1, 2, 3, 4, 5 or 6; the s4 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8.
[0157] Preferably, L0 and L1 are the same or different and are selected from a single bond, or one or a combination of the following groups:
[0158]
[0159] The R t the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, or two adjacent R t Bonding to form a substituted or unsubstituted ring;
[0160] The e1 is selected from 0, 1, 2, 3 or 4; the e2 is selected from 0, 1, 2, 3, 4, 5 or 6; the e3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the e4 is selected from 0, 1, 2 or 3; the e5 is selected from 0, 1 or 2; the e6 is selected from 0 or 1; the e7 is selected from 0, 1, 2, 3, 4 or 5; the e8 is selected from 0, 1, 2, 3, 4, 5, 6 or 7.
[0161] Preferably, the heterocyclic compound is selected from any one of the following structures:
[0162]
[0163]
[0164]
[0165]
[0166]
[0167]
[0168]
[0169]
[0170]
[0171]
[0172]
[0173]
[0174]
[0175]
[0176]
[0177]
[0178]
[0179]
[0180]
[0181]
[0182]
[0183]
[0184]
[0185]
[0186]
[0187]
[0188]
[0189]
[0190]
[0191]
[0192]
[0193]
[0194]
[0195] Some specific chemical structures of the heterocyclic compounds represented by Formula 1 of the present invention are listed above, but the present invention is not limited to these listed chemical structures, and all the groups based on the structure represented by Formula 1 and having substituents as defined above should be included.
[0196] In addition, the present invention further provides an organic electroluminescent device, which includes a first electrode; a second electrode arranged opposite to the first electrode; and an organic layer arranged between the first electrode and the second electrode, wherein the organic layer contains the heterocyclic compound described in the present invention.
[0197] Preferably, the organic layer includes at least one of a hole transport region, a light-emitting layer and an electron transport region, and at least one of the electron transport region and the light-emitting layer contains the heterocyclic compound described in the present invention.
[0198] Preferably, the organic layer is located between the first electrode and the second electrode, and the organic layer includes an electron transport region, and the electron transport region contains the heterocyclic compound described in the present invention.
[0199] Preferably, the organic layer is located between the first electrode and the second electrode, the organic layer includes an electron transport region, the electron transport region includes at least one layer of an electron injection layer, an electron transport layer, and a hole blocking layer, and at least one layer of the electron injection layer, the electron transport layer, and the hole blocking layer contains the heterocyclic compound described in the present invention.
[0200] Preferably, the organic layer is located between the first electrode and the second electrode, the organic layer includes an electron transport region, the electron transport region includes an electron transport layer, and the electron transport layer contains the heterocyclic compound described in the present invention.
[0201] Preferably, the organic layer is located between the first electrode and the second electrode, the organic layer includes an electron transport region, the electron transport region includes a hole blocking layer, and the hole blocking layer contains the heterocyclic compound described in the present invention.
[0202] Preferably, the organic layer is located between the first electrode and the second electrode, the organic layer includes an electron transport region, the electron transport region includes an electron transport layer and a hole blocking layer, and the electron transport layer and the hole blocking layer contain the heterocyclic compound described in the present invention.
[0203] Preferably, the organic layer is located between the first electrode and the second electrode, and the organic layer includes a light-emitting layer, and the light-emitting layer contains the heterocyclic compound described in the present invention.
[0204] Preferably, the organic layer is located between the first electrode and the second electrode, the organic layer includes a light-emitting layer, the light-emitting layer includes a host material, and the host material contains the heterocyclic compound described in the present invention.
[0205] Preferably, the organic electroluminescent device described in the present invention is divided into a single-layer organic electroluminescent device and a stacked organic electroluminescent device. The single-layer organic electroluminescent device is an organic electroluminescent device containing one light-emitting unit, and the stacked organic electroluminescent device is an organic electroluminescent device formed by connecting two or more independent light-emitting units in series through a charge generation layer.
[0206] Preferably, the organic electroluminescent device described in the present invention is a single-layer organic electroluminescent device, which comprises a first electrode, a second electrode and an organic layer arranged between the first electrode and the second electrode, and the organic layer contains the heterocyclic compound described in the present invention.
[0207] Preferably, the organic electroluminescent device described in the present invention is a stacked organic electroluminescent device, which comprises a first electrode, a second electrode, and an organic layer located between the first electrode and the second electrode, wherein the organic layer contains the heterocyclic compound described in the present invention.
[0208] Preferably, the organic layer is located between the first electrode and the second electrode, the organic layer includes a first stack that emits light of a first color and a second stack that emits light of a second color, and a charge generation layer located between the first stack and the second stack, the charge generation layer includes an N-type charge generation layer arranged adjacent to the first stack and a P-type charge generation layer arranged adjacent to the second stack, and the N-type charge generation layer contains the heterocyclic compound described in the present invention.
[0209] Preferably, the N-type charge generation layer can be formed by doping the heterocyclic compound described in the present invention with other materials.
[0210] Preferably, the first electrode is an anode and the second electrode is a cathode, or the first electrode is a cathode and the second electrode is an anode.
[0211] The organic electroluminescent device described in the present invention may further include a substrate. The substrate described in the present invention is preferably made of a material that does not change when forming electrodes and other functional layers. Specific examples of substrate materials that can be used in the present invention may include glass, quartz, plastic, polymer film, silicon, etc., but are not limited thereto.
[0212] The present invention has no particular limitation on the materials of the thin films in the organic electroluminescent device, and materials known in the art can be used. The organic functional layers of the organic electroluminescent device mentioned above and the electrodes on both sides of the device are introduced below:
[0213] The anode material of the present invention preferably uses a material with a high work function. The anode material includes metals, alloys and mixtures thereof with a high work function, but is not limited thereto. Specific examples of the anode material may include indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO2), zinc oxide (ZnO), magnesium (Mg), gold (Au), silver (Ag), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag), etc., but are not limited thereto.
[0214] The hole injection layer of the present invention is preferably a material with good hole injection ability. Specific examples of the hole injection layer material may include metal oxides, phthalocyanine compounds, benzidine compounds, phenazine compounds and other materials, such as copper phthalocyanine (CuPc), 4,4',4"-tri[2-naphthylphenylamino]triphenylamine (2-TNATA), 2,3,6,7,10,11-hexacyano-1,4,5,8,9,12-hexaazatriphenylene (HAT-CN), etc., but are not limited thereto.
[0215] The hole transport layer of the present invention is preferably a material with high hole mobility. The hole transport material includes carbazole derivatives, triarylamine derivatives, biphenyl diamine derivatives, fluorene derivatives, phthalocyanine compounds, quinacridone compounds, anthraquinone compounds, etc., but is not limited thereto. Specific examples of the hole transport material may include N, N'-diphenyl-N, N'-(1-naphthyl)-1, 1'-biphenyl-4, 4'-diamine (NPB), N4, N4'-di(biphenyl-4-yl)-N4, N4'-diphenylbiphenyl-4, 4'-diamine (TPD-10), 4, 4'-cyclohexylbis[N, N-di(4-methylphenyl)aniline] (TAPC), 4, 4', 4"-tri(carbazole-9-yl)triphenylamine (TCTA), etc., but are not limited thereto.
[0216] The electron blocking layer of the present invention is preferably a material that matches the energy level of the hole transport layer and has electron blocking ability. The electron blocking material includes aromatic amine derivatives, carbazole derivatives, spirofluorene derivatives, etc., but is not limited thereto. Specific examples may include N, N'-di(naphthalene-1-yl)-N, N'-diphenyl-benzidine (NPD), N, N-di([1, 1'-biphenyl]-4-)-(9H-carbazole-9-yl)-[1, 1'-biphenyl]-4-amine, etc., but are not limited thereto.
[0217] The light-emitting layer of the present invention comprises a host material and a guest material. The host material comprises heterocyclic compounds, metal complexes, fused polycyclic aromatic hydrocarbon compounds, aromatic amine compounds, etc., but is not limited thereto. Specific examples may include 4,4'-bis(carbazole-9-yl)biphenyl (CBP), 1,3-bis(N-carbazole)benzene (MCP), 1,3,5-tri(carbazole-9-yl)benzene (TCP), 9,10-di(2-naphthyl)anthracene (ADN), etc., but are not limited thereto. The heterocyclic compound of the present invention is preferred. The guest material comprises heavy metal complexes, rare earth metal complexes, etc., but is not limited thereto. Specific examples may include tris(2-phenylpyridine)iridium (Ir(ppy)3), bis(1-phenyl-isoquinoline)(acetylacetonate)iridium (Ir(piq)2(acac)), tris(1-phenyl-isoquinoline)iridium (Ir(piq)3), 2,5,8,11-tetra-tert-butylperylene (TBPe), etc., but are not limited thereto.
[0218] The hole blocking layer of the present invention preferably uses a material with a suitable energy level and hole blocking ability. Specific examples of the hole blocking layer material may include imidazole derivatives, triazole derivatives, phenanthroline derivatives and other materials, such as 1,3,5-tris (1-phenyl-1H-benzimidazole-2-yl) benzene (TPBi), 3- (biphenyl-4-yl) -5- (4-tert-butylphenyl) -4-phenyl-4H-1,2,4-triazole (TAZ), bis (2-methyl-8-hydroxyquinoline) (4-phenylphenol) aluminum (III) (BAlq), etc., but not limited thereto. The heterocyclic compound of the present invention is preferred.
[0219] The electron transport layer of the present invention preferably has a material with high electron mobility and good thermal stability. The electron transport layer material may include a metal complex, an oxazole derivative, a thiazole derivative, a quinoline derivative, a triazine derivative, and a polymer compound, etc., and the specific examples of the electron transport layer material may include 8-hydroxyquinoline lithium (LiQ), 8-hydroxyquinoline aluminum (Alq3), bis (2-methyl-8-hydroxyquinoline-N1, O8)-(1,1'-biphenyl-4-hydroxy) aluminum (BAlq), 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), 4,4'bis (4,6-diphenyl-1,3,5-triazine-2-yl) biphenyl (BTB), etc., but are not limited thereto. The heterocyclic compound of the present invention is preferred.
[0220] The electron injection layer of the present invention preferably has a material with good electron injection ability. The electron injection layer material includes alkali metals, alkali metal compounds, alkali metal complexes, alkaline earth metal complexes and rare earth metal complexes, but is not limited thereto. Specific examples of the electron injection material may include lithium (Li), lithium fluoride (LiF), sodium fluoride (NaF), 8-hydroxyquinoline lithium (LiQ), lithium oxide (Li2O), barium oxide (BaO), cesium carbonate (Cs2CO3), etc., but are not limited thereto.
[0221] The cathode material of the present invention preferably has a material with a low work function. The cathode material includes metals, alloys and mixtures thereof with a low work function, but is not limited thereto. Specific examples of the cathode material may include metals and alloys such as magnesium (Mg), calcium (Ca), sodium (Na), potassium (K), titanium (Ti), indium (In), lithium (Li), aluminum (Al), silver (Ag), tin or lead, LiF / Al or LiO2 / Al multilayer structures, but are not limited thereto.
[0222] The cover layer material of the present invention preferably uses a material with a suitable refractive index. The cover layer material includes aromatic amine compounds, metal compounds, etc., but is not limited thereto. Specific examples of the cover layer material may include tris(8-hydroxyquinoline)aluminum (Alq3), 4,4'-bis(carbazole-9-yl)biphenyl (CBP), zirconium oxide (ZrO), zinc oxide (ZnO), etc., but are not limited thereto.
[0223] Specific examples of the N-type charge generation material of the present invention may include tris-(8-hydroxyquinolinate)aluminum (Alq3), quinolate lithium (Liq), bis(2-methyl-8-quinolinate-N1,08)-(1,1'-biphenyl-4-phenolate)aluminum (BAlq), 4,7-diphenyl*1,10-phenanthroline (Bphen), 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), 1,3,5-tris(p-pyridin-3-yl-phenyl)benzene (TpPyPB), etc., or doped with alkali metals or alkaline earth metals, but are not limited thereto. The heterocyclic compound of the present invention is preferred.
[0224] Specific examples of the P-type charge generating material described in the present invention may include N,N'-diphenyl-N,N'-bis(1-naphthyl)-1,1'-biphenyl-4,4"-diamine (NPD), 4,4',4"-tri(N-(naphthalene-2-yl)-N-phenyl-amino)triphenylamine (2T-NATA), copper phthalocyanine (CuPc), 2,3,6,7,10,11-hexacyano-1,4,5,8,9,12-hexaazatriphenylene (HAT-CN), etc., but are not limited thereto.
[0225] There is no particular limitation on the method for preparing the thin films in the organic electroluminescent device of the present invention, and vacuum evaporation, sputtering, spin coating, spray coating, screen printing, laser transfer, etc. may be used, but are not limited thereto.
[0226] The organic electroluminescent device of the present invention is mainly used in the fields of information display technology, lighting, and organic solar cells, such as mobile phones, tablet computers, flat-screen TVs, various wearable devices, etc.
[0227] The present invention is described in more detail with reference to the following examples. However, the following examples are only used to illustrate the present description, and the scope of the present description is not limited to these examples.
[0228] Synthesis Example
[0229] Raw materials and reagents: The present invention has no particular restrictions on the raw materials or reagents used in the following synthetic examples, and they can be commercially available products or prepared by preparation methods well known to those skilled in the art. The raw materials and reagents used in the present invention are all reagent-grade.
[0230] Instruments: G2-Si quadrupole tandem time-of-flight high-resolution mass spectrometer (Waters, UK); Vario ELcube organic element analyzer (Elementar, Germany).
[0231] There is no particular limitation on the preparation method of the heterocyclic compound represented by Formula 1 of the present invention, and conventional methods known to those skilled in the art can be used. For example, carbon-carbon coupling reaction, etc. The heterocyclic compound represented by Formula 1 of the present invention can be prepared by the synthetic route shown below.
[0232] Synthesis route 1: When Ar-L0-* is the same as Ar1-L1-*, the synthesis route of the compound of formula 1 is as follows:
[0233]
[0234] Synthesis route 2: When and are different, the synthesis route of the compound of formula 1 is as follows:
[0235]
[0236] The Xn is a halogen, for example, Xn are the same or different and are selected from Cl, Br, and I.
[0237] Ar0, Ar1, L0, L1, L2, R2, R3, Ra, Rb, n1, and n2 are the same as defined above.
[0238] Synthesis Example 1: Synthesis of Compound 13
[0239]
[0240] Preparation of intermediate c-13: Under nitrogen protection, a-13 (20.49 g, 75.00 mmol), b-13 (11.73 g, 75.00 mmol), Na2CO3 (11.92 g, 112.50 mmol), Pd(PPh3)4 (0.87 g, 0.75 mmol), 450 mL toluene / ethanol / water (2:1:1) were added to the reaction bottle, and the mixture was stirred under reflux for 5 hours. After the reaction, the reaction mixture was cooled to room temperature, filtered, washed with distilled water, and then the obtained solid was recrystallized with toluene / ethanol = 9:1 to obtain intermediate c-13 (18.75 g, yield 82%); HPLC detected the solid purity ≧99.72%. Mass spectrum m / z: 304.1030 (theoretical value: 304.1019).
[0241] Preparation of intermediate d-13: Under nitrogen protection, c-13 (15.24 g, 50.00 mmol), biboronic acid pinacol ester (12.70 g, 50.00 mmol), CH3COOK (9.81 g, 100.00 mmol), Pd(dppf)Cl2 (0.37 g, 0.50 mmol) and 300 mL DMF were added to the reaction bottle, and the mixture was stirred under reflux for 6 hours. After the reaction was completed, the mixture was cooled to room temperature, distilled water was added, and then extracted with dichloromethane. The organic layer was dried over anhydrous magnesium sulfate, the solvent was concentrated by vacuum distillation, the temperature was lowered for crystallization, suction filtered, and then recrystallized from toluene to obtain intermediate d-13 (15.85 g, yield 80%); HPLC purity ≧99.79%. Mass spectrum m / z: 396.2241 (theoretical value: 396.2261).
[0242] Preparation of intermediate B-13: Under nitrogen protection, e-13 (9.22 g, 50.00 mmol), f-13 (23.90 g, 100.00 mmol), K2CO3 (20.73 g, 150.00 mmol), Pd(PPh3)4 (1.16 g, 1.00 mmol), and 250 mL of 1,4-dioxane were added to the reaction bottle, and the mixture was stirred under reflux for 5.5 hours. After the reaction, the reaction mixture was cooled to room temperature, extracted with dichloromethane, and the organic layer was dried with anhydrous MgSO4. The solvent was removed under reduced pressure, and the mixture was recrystallized with ethyl acetate to obtain intermediate B-13 (19.07 g, yield 76%); HPLC detected the solid purity ≧99.82%. Mass spectrum m / z: 501.0979 (theoretical value: 501.0993).
[0243] Preparation of compound 13: Under nitrogen protection, add B-13 (15.06 g, 30.00 mmol), d-13 (11.89 g, 30.00 mmol), K2CO3 (6.22 g, 45.00 mmol), Pd(OAc)2 (0.07 g, 0.30 mmol), P(t-Bu)3 (0.06 g, 0.30 mmol), 200 mL toluene / ethanol / water (2:1:1) to the reaction bottle, stir and react under reflux conditions for 6.5 hours. After the reaction, the reaction mixture is cooled to room temperature, filtered, washed with distilled water, and then the obtained solid is recrystallized from toluene to obtain compound 13 (16.12 g, yield 73%); HPLC detection solid purity ≧99.94%. Mass spectrum m / z: 735.2643 (theoretical value: 735.2634). Theoretical element content (%) C 50 H 33 N5O2: C, 81.61; H, 4.52; N, 9.52. Measured element content (%): C, 81.59; H, 4.48; N, 9.57.
[0244] Synthesis Example 2: Synthesis of Compound 27
[0245]
[0246] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-27 and f-27 respectively, and the other steps were the same to obtain compound 27 (15.89 g). The solid purity detected by HPLC was ≥99.92%. Mass spectrum m / z: 735.2620 (theoretical value: 735.2634). Theoretical element content (%) C 50 H 33 N5O2: C, 81.61; H, 4.52; N, 9.52. Measured element content (%): C, 81.58; H, 4.54; N, 9.49.
[0247] Synthesis Example 3: Synthesis of Compound 33
[0248]
[0249] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 and f-13 were replaced by equimolar amounts of b-33 and f-33, respectively, and the other steps were the same to obtain compound 33 (15.45 g). The solid purity detected by HPLC was ≥99.98%. Mass spectrum m / z: 735.2644 (theoretical value: 735.2634). Theoretical element content (%) C 50 H 33N5O2: C, 81.61; H, 4.52; N, 9.52. Measured element content (%): C, 81.65; H, 4.50; N, 9.49.
[0250] Synthesis Example 4: Synthesis of Compound 52
[0251]
[0252] According to the same preparation method as compound 13 in Synthesis Example 1, a-13, b-13, and f-13 were replaced by equimolar a-52, b-52, and f-52, respectively, and the other steps were the same to obtain compound 52 (15.67 g). The solid purity detected by HPLC was ≥99.91%. Mass spectrum m / z: 735.2642 (theoretical value: 735.2634). Theoretical element content (%) C 50 H 33 N5O2: C, 81.61; H, 4.52; N, 9.52. Measured element content (%): C, 81.59; H, 4.54; N, 9.48.
[0253] Synthesis Example 5: Synthesis of Compound 86
[0254]
[0255] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-86 and f-86 respectively, and the other steps were the same to obtain compound 86 (16.10 g). The solid purity detected by HPLC was ≥99.96%. Mass spectrum m / z: 777.3121 (theoretical value: 777.3104). Theoretical element content (%) C 53 H 39 N5O2: C, 81.83; H, 5.05; N, 9.00. Measured element content (%): C, 81.78; H, 5.08; N, 9.02.
[0256] Synthesis Example 6: Synthesis of Compound 101
[0257]
[0258] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-101 and f-101, respectively, and the other steps were the same to obtain compound 101 (15.92 g). The solid purity detected by HPLC was ≥99.95%. Mass spectrum m / z: 757.3425 (theoretical value: 757.3417). Theoretical element content (%) C 51 H 43N5O2: C, 80.82; H, 5.72; N, 9.24. Measured element content (%): C, 80.78; H, 5.75; N, 9.22.
[0259] Synthesis Example 7: Synthesis of Compound 107
[0260]
[0261] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 was replaced with an equal molar amount of a-107, and the other steps were the same to obtain compound 107 (17.11 g). The solid purity detected by HPLC was ≥99.97%. Mass spectrum m / z: 791.3277 (theoretical value: 791.3260). Theoretical element content (%) C 54 H 41 N5O2: C, 81.90; H, 5.22; N, 8.84. Measured element content (%): C, 81.86; H, 5.25; N, 8.82.
[0262] Synthesis Example 8: Synthesis of Compound 137
[0263]
[0264] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 was replaced with an equal molar amount of b-137, and the other steps were the same to obtain compound 137 (16.08 g). The solid purity detected by HPLC was ≥99.94%. Mass spectrum m / z: 811.2964 (theoretical value: 811.2947). Theoretical element content (%) C 56 H 37 N5O2: C, 82.84; H, 4.59; N, 8.63. Measured element content (%): C, 82.86; H, 4.61; N, 8.59.
[0265] Synthesis Example 9: Synthesis of Compound 158
[0266]
[0267] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 and f-13 were replaced by equimolar amounts of b-158 and f-158, respectively, and the other steps were the same to obtain compound 158 (15.33 g). The solid purity detected by HPLC was ≥99.98%. Mass spectrum m / z: 785.2781 (theoretical value: 785.2791). Theoretical element content (%) C 54 H 35N5O2: C, 82.53; H, 4.49; N, 8.91. Measured element content (%): C, 82.49; H, 4.51; N, 8.89.
[0268] Synthesis Example 10: Synthesis of Compound 159
[0269]
[0270] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 was replaced with an equal molar amount of b-159, and the other steps were the same to obtain compound 159 (15.54 g). The solid purity detected by HPLC was ≥99.93%. Mass spectrum m / z: 739.2871 (theoretical value: 739.2885). Theoretical element content (%) C 50 H 29 D4N5O2: C, 81.17; H, 5.04; N, 9.47. Measured element content (%): C, 81.20; H, 5.01; N, 9.49.
[0271] Synthesis Example 11: Synthesis of Compound 163
[0272]
[0273] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 and f-13 were replaced by equimolar amounts of b-163 and f-163, respectively, and the other steps were the same to obtain compound 163 (15.97 g). The solid purity detected by HPLC was ≥99.97%. Mass spectrum m / z: 749.2772 (theoretical value: 749.2791). Theoretical element content (%) C 51 H 35 N5O2: C, 81.69; H, 4.70; N, 9.34. Measured element content (%): C, 81.72; H, 4.66; N, 9.36.
[0274] Synthesis Example 12: Synthesis of Compound 178
[0275]
[0276] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 and f-13 were replaced by equimolar amounts of b-178 and f-178, respectively, and the other steps were the same to obtain compound 178 (15.89 g). The solid purity detected by HPLC was ≥99.92%. Mass spectrum m / z: 840.3222 (theoretical value: 840.3213). Theoretical element content (%) C 57 H 40N6O2: C, 81.41; H, 4.79; N, 9.99. Measured element content (%): C, 81.39; H, 4.83; N, 9.96.
[0277] Synthesis Example 13: Synthesis of Compound 189
[0278]
[0279] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 was replaced with an equal molar amount of a-189, and the other steps were the same to obtain compound 189 (18.06 g). The solid purity detected by HPLC was ≥99.95%. Mass spectrum m / z: 859.2965 (theoretical value: 859.2947). Theoretical element content (%) C 60 H 37 N5O2: C, 83.80; H, 4.34; N, 8.14. Measured element content (%): C, 83.76; H, 4.37; N, 8.16.
[0280] Synthesis Example 14: Synthesis of Compound 232
[0281]
[0282] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 was replaced by an equal molar amount of a-232, and the other steps were the same to obtain compound 232 (18.12 g). The solid purity detected by HPLC was ≥99.96%. Mass spectrum m / z: 887.3268 (theoretical value: 887.3260). Theoretical element content (%) C 62 H 41 N5O2: C, 83.86; H, 4.65; N, 7.89. Measured element content (%): C, 83.82; H, 4.68; N, 7.91.
[0283] Synthesis Example 15: Synthesis of Compound 262
[0284]
[0285] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-262 and f-27 respectively, and the other steps were the same to obtain compound 262 (18.41 g). The solid purity detected by HPLC was ≥99.91%. Mass spectrum m / z: 915.3585 (theoretical value: 915.3573). Theoretical element content (%) C 64 H 45N5O2: C, 83.91; H, 4.95; N, 7.64. Measured element content (%): C, 83.86; H, 4.97; N, 7.67.
[0286] Synthesis Example 16: Synthesis of Compound 303
[0287]
[0288] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-303 and f-158 respectively, and the other steps were the same to obtain compound 303 (18.02 g). The solid purity detected by HPLC was ≥99.94%. Mass spectrum m / z: 857.2782 (theoretical value: 857.2791). Theoretical element content (%) C 60 H 35 N5O2: C, 84.00; H, 4.11; N, 8.16. Measured element content (%): C, 84.03; H, 4.09; N, 8.20.
[0289] Synthesis Example 17: Synthesis of Compound 349
[0290]
[0291] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 and f-13 were replaced by equimolar amounts of b-52 and f-349, respectively, and the other steps were the same to obtain compound 349 (16.59 g). The solid purity detected by HPLC was ≥99.92%. Mass spectrum m / z: 767.2187 (theoretical value: 767.2177). Theoretical element content (%) C 50 H 33 N5S2: C, 78.20; H, 4.33; N, 9.12. Measured element content (%): C, 78.17; H, 4.35; N, 9.09.
[0292] Synthesis Example 18: Synthesis of Compound 391
[0293]
[0294] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-391 and f-391, respectively, and the other steps were the same to obtain compound 391 (16.51 g). The solid purity detected by HPLC was ≥99.98%. Mass spectrum m / z: 774.2636 (theoretical value: 774.2617). Theoretical element content (%) C 50 H 26D7N5S2: C, 77.49; H, 5.20; N, 9.04. Measured element content (%): C, 77.52; H, 5.17; N, 9.06.
[0295] Synthesis Example 19: Synthesis of Compound 394
[0296]
[0297] According to the same preparation method as compound 13 in Synthesis Example 1, a-13, b-13, and f-13 were replaced by equimolar a-52, b-394, and f-394, respectively, and the other steps were the same to obtain compound 394 (16.40 g). The solid purity detected by HPLC was ≥99.96%. Mass spectrum m / z: 815.2978 (theoretical value: 815.2993). Theoretical element content (%) C 53 H 29 D8N5S2: C, 78.00; H, 5.56; N, 8.58. Measured element content (%): C, 78.03; H, 5.52; N, 8.60.
[0298] Synthesis Example 20: Synthesis of Compound 401
[0299]
[0300] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-401 and f-349, respectively, and the other steps were the same to obtain compound 401 (17.47 g). The solid purity detected by HPLC was ≥99.91%. Mass spectrum m / z: 843.2470 (theoretical value: 843.2490). Theoretical element content (%) C 56 H 37 N5S2: C, 79.69; H, 4.42; N, 8.30. Measured element content (%): C, 79.71; H, 4.38; N, 8.28.
[0301] Synthesis Example 21: Preparation of Compound 414
[0302]
[0303] Preparation of intermediate c-414: Under nitrogen protection, a-414 (24.24 g, 75.00 mmol), b-13 (11.73 g, 75.00 mmol), Na2CO3 (11.92 g, 112.50 mmol), Pd(PPh3)4 (0.87 g, 0.75 mmol), 450 mL toluene / ethanol / water (2:1:1) were added to the reaction bottle, and the mixture was stirred and reacted for 5 hours under reflux conditions. After the reaction was completed, the reaction mixture was cooled to room temperature, filtered, washed with distilled water, and then the obtained solid was recrystallized from toluene to obtain intermediate c-414 (21.56 g, yield 81%); HPLC detected the solid purity ≧99.70%. Mass spectrum m / z: 354.1167 (theoretical value: 354.1175).
[0304] Preparation of intermediate d-414: Under nitrogen protection, c-414 (17.74 g, 50.00 mmol), biboronic acid pinacol ester (12.70 g, 50.00 mmol), K2CO3 (13.82 g, 100.00 mmol), Pd(dppf)Cl2 (0.37 g, 0.50 mmol), 350 mL DMF were added to the reaction bottle, and the reaction was stirred under reflux for 6 hours. After the reaction was completed, it was cooled to room temperature, distilled water was added, and then extracted with dichloromethane, the organic layer was dried over anhydrous magnesium sulfate, the solvent was concentrated by vacuum distillation, the temperature was lowered for crystallization, suction filtered, and then recrystallized from toluene to obtain intermediate d-414 (17.63 g, yield 79%); HPLC purity ≧99.74%. Mass spectrum m / z: 446.2430 (theoretical value: 446.2417).
[0305] Preparation of intermediate A-414: Under nitrogen protection, e-13 (14.75 g, 80.00 mmol), f-13 (19.12 g, 80.00 mmol), Na2CO3 (12.72 g, 120.00 mmol), Pd(PPh3)4 (0.92 g, 0.80 mmol), 500 mL toluene / ethanol / water (2:1:1) were added to the reaction bottle, and the mixture was stirred under reflux for 5.5 hours. After the reaction, the reaction mixture was cooled to room temperature, filtered, washed with distilled water, and then the obtained solid was recrystallized with toluene / ethanol = 9:1 to obtain intermediate A-414 (21.14 g, yield 77%); HPLC detected the solid purity ≧99.75%. Mass spectrum m / z: 342.0060 (theoretical value: 342.0075).
[0306] Preparation of intermediate B-414: Under nitrogen protection, A-414 (17.16 g, 50.00 mmol), f-349 (11.95 g, 50.00 mmol), K2CO3 (10.37 g, 75.00 mmol), Pd(dppf)Cl2 (0.37 g, 0.50 mmol), and 350 mL of 1,4-dioxane were added to the reaction bottle, and the mixture was stirred under reflux for 6.5 hours. After the reaction, the reaction mixture was cooled to room temperature, extracted with dichloromethane, and the organic layer was dried with anhydrous MgSO4. The solvent was removed under reduced pressure and recrystallized with ethyl acetate to obtain intermediate B-414 (19.17 g, yield 74%); HPLC detected the solid purity ≧99.82%. Mass spectrum m / z: 517.0774 (theoretical value: 517.0764).
[0307] Preparation of compound 414: Under nitrogen protection, add B-414 (15.54 g, 30.00 mmol), d-414 (13.39 g, 30.00 mmol), Na2CO3 (4.77 g, 45.00 mmol), Pd(OAc)2 (0.07 g, 0.30 mmol), P(t-Bu)3 (0.06 g, 0.30 mmol), 200 mL toluene / ethanol / water (2:1:1) to the reaction bottle, stir and react under reflux for 7.5 hours. After the reaction, the reaction mixture is cooled to room temperature, filtered, washed with distilled water, and then the obtained solid is recrystallized from toluene to obtain compound 414 (17.32 g, yield 72%); HPLC detection solid purity ≧99.93%. Mass spectrum m / z: 801.2550 (theoretical value: 801.2562). Theoretical element content (%) C 54 H 35 N5OS: C, 80.88; H, 4.40; N, 8.73. Measured element content (%): C, 80.91; H, 4.38; N, 8.76.
[0308] Synthesis Example 22: Preparation of Compound 475
[0309]
[0310] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, and f-13 were replaced by equimolar a-189, b-137, and f-475, respectively, and the other steps were the same to obtain compound 475 (18.59 g). The solid purity detected by HPLC was ≥99.97%. Mass spectrum m / z: 967.2822 (theoretical value: 967.2803). Theoretical element content (%) C 66 H 41N5S2: C, 81.88; H, 4.27; N, 7.23. Measured element content (%): C, 81.90; H, 4.30; N, 7.18.
[0311] Synthesis Example 23: Preparation of Compound 534
[0312]
[0313] According to the same preparation method as compound 13 in Synthesis Example 1, a-13, b-13, e-13, and f-13 were replaced by equimolar a-52, b-534, e-534, and f-534, respectively, and the other steps were the same to obtain compound 534 (15.41 g). The solid purity detected by HPLC was ≥99.92%. Mass spectrum m / z: 733.2720 (theoretical value: 733.2729). Theoretical element content (%) C 52 H 35 N3O2: C, 85.11; H, 4.81; N, 5.73. Measured element content (%): C, 85.07; H, 4.79; N, 5.77.
[0314] Synthesis Example 24: Preparation of Compound 635
[0315]
[0316] According to the same preparation method as compound 13 in Synthesis Example 1, a-13, e-13, and f-13 were replaced by equimolar a-635, e-635, and f-635, respectively, and the other steps were the same to obtain compound 635 (19.11 g). The solid purity detected by HPLC was ≥99.98%. Mass spectrum m / z: 964.3790 (theoretical value: 964.3777). Theoretical element content (%) C 69 H 48 N4O2: C, 85.87; H, 5.01; N, 5.80. Measured element content (%): C, 85.90; H, 5.03; N, 5.76.
[0317] Synthesis Example 25: Preparation of Compound 666
[0318]
[0319] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, f-13, and f-349 were replaced by equimolar a-13, f-666, and f-27, respectively, and the other steps were the same to obtain compound 666 (15.24 g). The solid purity was ≥99.91% by HPLC. Mass spectrum m / z: 695.2669 (theoretical value: 695.2685). Theoretical element content (%) C48 H 33 N5O: C, 82.86; H, 4.78; N, 10.07. Measured element content (%): C, 82.88; H, 4.73; N, 10.10.
[0320] Synthesis Example 26: Preparation of Compound 679
[0321]
[0322] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, f-13, and f-349 were replaced by equimolar a-679, f-679, and g-679, respectively, and the other steps were the same to obtain compound 679 (15.92 g). The solid purity detected by HPLC was ≥99.95%. Mass spectrum m / z: 791.3252 (theoretical value: 791.3260). Theoretical element content (%) C 54 H 41 N5O2: C, 81.90; H, 5.22; N, 8.84. Measured element content (%): C, 81.86; H, 5.19; N, 8.88.
[0323] Synthesis Example 27: Preparation of Compound 685
[0324]
[0325] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, f-13, and f-349 were replaced by equimolar a-13, f-685, and f-13, respectively, and the other steps were the same to obtain compound 685 (15.21 g). The solid purity was ≥99.96% by HPLC. Mass spectrum m / z: 734.3058 (theoretical value: 734.3046). Theoretical element content (%) C 52 H 38 N4O: C, 84.99; H, 5.21; N, 7.62. Measured element content (%): C, 84.94; H, 5.23; N, 7.65.
[0326] Synthesis Example 28: Preparation of Compound 688
[0327]
[0328] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, f-13, and f-349 were replaced by equimolar a-688, b-52, f-688, and g-688, respectively, and the other steps were the same to obtain compound 688 (15.38 g). The solid purity was ≥99.93% by HPLC. Mass spectrum m / z: 776.3530 (theoretical value: 776.3515). Theoretical element content (%) C 55 H 44 N4O: C, 85.02; H, 5.71; N, 7.21. Measured element content (%): C, 85.06; H, 5.69; N, 7.18.
[0329] Synthesis Example 29: Preparation of Compound 695
[0330]
[0331] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, f-13, and f-349 were replaced by equimolar a-13, f-695, and f-13, respectively, and the other steps were the same to obtain compound 695 (13.92 g). The solid purity detected by HPLC was ≥99.92%. Mass spectrum m / z: 618.2403 (theoretical value: 618.2420). Theoretical element content (%) C 43 H 30 N4O: C, 83.47; H, 4.89; N, 9.06. Measured element content (%): C, 83.42; H, 4.91; N, 9.09.
[0332] Synthesis Example 30: Preparation of Compound 759
[0333]
[0334] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, f-13, and f-349 were replaced by equimolar a-52, b-759, f-759, and f-158, respectively, and the other steps were the same to obtain compound 759 (15.50 g). The solid purity was ≥99.98% by HPLC. Mass spectrum m / z: 770.3059 (theoretical value: 770.3046). Theoretical element content (%) C 55 H 38 N4O: C, 85.69; H, 4.97; N, 7.27. Measured element content (%): C, 85.73; H, 4.93; N, 7.29.
[0335] Synthesis Example 31: Preparation of Compound 793
[0336]
[0337] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, f-13, and f-349 were replaced by equimolar a-13, b-52, f-695, and f-163, respectively, and the other steps were the same to obtain compound 793 (13.74 g). The solid purity detected by HPLC was ≥99.91%. Mass spectrum m / z: 618.2401 (theoretical value: 618.2420). Theoretical element content (%) C 43 H 30 N4O: C, 83.47; H, 4.89; N, 9.06. Measured element content (%): C, 83.50; H, 4.86; N, 9.08.
[0338] Synthesis Example 32: Preparation of Compound 798
[0339]
[0340] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, f-13, and f-349 were replaced by equimolar a-189, f-798, and f-13, respectively, and the other steps were the same to obtain compound 798 (16.30 g). The solid purity detected by HPLC was ≥99.97%. Mass spectrum m / z: 798.3349 (theoretical value: 798.3359). Theoretical element content (%) C 57 H 42 N4O: C, 85.69; H, 5.30; N, 7.01. Measured element content (%): C, 85.71; H, 5.27; N, 7.05.
[0341] Synthesis Example 33: Preparation of Compound 848
[0342]
[0343] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, f-13, and f-349 were replaced by equimolar a-303, b-52, f-848, and f-158, respectively, and the other steps were the same to obtain compound 848 (15.90 g). The solid purity was ≥99.92% by HPLC. Mass spectrum m / z: 790.2747 (theoretical value: 790.2733). Theoretical element content (%) C 57 H 34 N4O: C, 86.56; H, 4.33; N, 7.08. Measured element content (%): C, 86.60; H, 4.29; N, 7.10.
[0344] Synthesis Example 34: Preparation of Compound 861
[0345]
[0346] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, f-13, and f-349 were replaced by equimolar a-861, b-52, f-861, and g-861, respectively, and the other steps were the same to obtain compound 861 (15.98 g). The solid purity detected by HPLC was ≥99.93%. Mass spectrum m / z: 858.4078 (theoretical value: 858.4094). Theoretical element content (%) C 60 H 42 D5N5O: C, 83.89; H, 6.10; N, 8.15. Measured element content (%): C, 83.91; H, 6.07; N, 8.18.
[0347] Synthesis Example 35: Preparation of Compound 893
[0348]
[0349] According to the same preparation method as compound 414 in Synthesis Example 21, a-414 and f-13 were replaced by equimolar a-893 and f-893, respectively, and the other steps were the same to obtain compound 893 (15.14 g). The solid purity detected by HPLC was ≥99.94%. Mass spectrum m / z: 741.2915 (theoretical value: 741.2926). Theoretical element content (%) C 50 H 39 N5S: C, 80.94; H, 5.30; N, 9.44. Measured element content (%): C, 80.90; H, 5.28; N, 9.49.
[0350] Synthesis Example 36: Preparation of Compound 895
[0351]
[0352] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, and f-13 were replaced by equimolar a-13, b-52, and f-895, respectively, and the other steps were the same to obtain compound 895 (15.55 g). The solid purity was ≥99.98% by HPLC. Mass spectrum m / z: 719.3051 (theoretical value: 719.3069). Theoretical element content (%) C 49 H 25 D9N4S: C, 81.75; H, 6.02; N, 7.78. Measured element content (%): C, 81.72; H, 6.06; N, 7.80.
[0353] Synthesis Example 37: Preparation of Compound 897
[0354]
[0355] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, f-13, and f-349 were replaced by equimolar a-897, f-897, and g-897, respectively, and the other steps were the same to obtain compound 897 (15.44 g). The solid purity was ≥99.96% by HPLC. Mass spectrum m / z: 767.2889 (theoretical value: 767.2879). Theoretical element content (%) C 51 H 29 D5N6S: C, 79.76; H, 5.12; N, 10.94. Measured element content (%): C, 79.80; H, 5.09; N, 10.92.
[0356] Synthesis Example 38: Preparation of Compound 966
[0357]
[0358] According to the same preparation method as compound 13 in Synthesis Example 1, b-13 and e-13 were replaced by equimolar amounts of b-52 and e-635, respectively, and the other steps were the same to obtain compound 966 (16.09 g). The solid purity detected by HPLC was ≥99.95%. Mass spectrum m / z: 734.2667 (theoretical value: 734.2682). Theoretical element content (%) C 51 H 34 N4O2: C, 83.36; H, 4.66; N, 7.62. Measured element content (%): C, 83.40; H, 4.63; N, 7.64.
[0359] Synthesis Example 39: Preparation of Compound 972
[0360]
[0361] According to the same preparation method as compound 414 in Synthesis Example 21, a-414, b-13, e-13, f-13, and f-349 were replaced by equimolar a-13, b-972, e-972, f-972, and f-13, respectively, and the other steps were the same to obtain compound 972 (15.10 g). The solid purity was ≥99.93% by HPLC. Mass spectrum m / z: 824.3527 (theoretical value: 824.3515). Theoretical element content (%) C 59 H 44N4O: C, 85.89; H, 5.38; N, 6.79. Measured element content (%): C, 85.92; H, 5.40; N, 6.75.
[0362] Synthesis Example 40: Preparation of Compound 973
[0363]
[0364] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and b-13 were replaced by equimolar a-973 and b-52 respectively, and the other steps were the same to obtain compound 973 (16.74 g). The solid purity detected by HPLC was ≥99.96%. Mass spectrum m / z: 785.2771 (theoretical value: 785.2791). Theoretical element content (%) C 54 H 35 N5O2: C, 82.53; H, 4.49; N, 8.91. Measured element content (%): C, 82.49; H, 4.51; N, 8.89;.
[0365] Synthesis Example 41: Preparation of Compound 975
[0366]
[0367] According to the same preparation method as compound 13 in Synthesis Example 1, a-13 and f-13 were replaced by equimolar a-975 and f-975, respectively, and the other steps were the same to obtain compound 975 (15.89 g). The solid purity detected by HPLC was ≥99.92%. Mass spectrum m / z: 735.2625 (theoretical value: 735.2634). Theoretical element content (%) C 50 H 33 N5O2: C, 81.61; H, 4.52; N, 9.52. Measured element content (%): C, 81.57; H, 4.54; N, 9.55.
[0368] Synthesis Example 42: Preparation of Compound 976
[0369]
[0370] According to the same preparation method as compound 414 in Synthesis Example 21, a-13, b-13, f-13, f-349, and d-414 were replaced by equimolar a-976, b-52, f-695, f-534, and d-976, respectively, and the other steps were the same to obtain compound 976 (14.60 g). The solid purity was ≥99.94% by HPLC. Mass spectrum m / z: 666.2405 (theoretical value: 666.2420). Theoretical element content (%) C 47H 30 N4O: C, 84.66; H, 4.54; N, 8.40. Measured element content (%): C, 84.70; H, 4.51; N, 8.38.
[0371] Device Embodiment
[0372] In the present invention, the ITO glass substrate and the ITO / Ag / ITO glass substrate are ultrasonically cleaned twice with 5% glass cleaning liquid for 20 minutes each time, and then ultrasonically cleaned twice with deionized water for 10 minutes each time. Acetone and isopropyl ketone are ultrasonically cleaned for 20 minutes in sequence, and dried at 120°C. The organic materials are all sublimated, and the purity is above 99.99%.
[0373] The test software, computer, K2400 digital source meter produced by Keithley Company of the United States and PR788 spectrum scanning luminance meter produced by PhotoResearch Company of the United States are combined into a joint IVL test system to test the driving voltage, luminous efficiency and CIE color coordinates of organic electroluminescent devices. The life test adopts the M6000 OLED life test system of McScience Company. The test environment is atmospheric environment and the temperature is room temperature.
[0374] Example 1: Preparation of organic electroluminescent device 1
[0375] HI-1 and HI-2 were vacuum evaporated on the ITO anode to form a hole injection layer with a ratio of HI-1:HI-2=5:95 (wt%), and the thickness was 12nm; HT-1 was vacuum evaporated on the hole injection layer as a hole transport layer with a thickness of 120nm; GH-1 and GH-2 were vacuum evaporated on the hole transport layer in a ratio of 1:1 (wt%) as main materials, and the doping material GD-1 was evaporated at a doping amount of 8wt% based on the total amount of the main material and the doping material to form a light-emitting layer with a thickness of 25nm; the compound 13 of the present invention and LiQ were vacuum evaporated on the light-emitting layer to form an electron transport layer with a ratio of the compound 13 of the present invention:LiQ=1:1 (wt%), and the thickness was 30nm; LiF was vacuum evaporated on the electron transport layer as an electron injection layer with a thickness of 1.0nm; Al was vacuum evaporated on the electron injection layer as a cathode with a thickness of 110nm.
[0376] Examples 2 to 33: Preparation of organic electroluminescent devices 2 to 33
[0377] The compound 13 in the electron transport layer of Example 1 is replaced by compound 27, compound 33, compound 52, compound 107, compound 137, compound 158, compound 159, compound 178, compound 189, compound 232, compound 262, compound 303, compound 349, compound 391, compound 401, compound 534, compound 635, compound 666, compound 685, compound 688, compound 695, compound 759, compound 793, compound 798, compound 848, compound 893, compound 895, compound 897, compound 966, compound 973, compound 975, and compound 976, respectively, and the other steps are the same to obtain organic electroluminescent devices 2 to 33.
[0378] Comparative Examples 1 to 7: Preparation of Comparative Organic Electroluminescent Devices 1 to 7
[0379] The compound 13 in the electron transport layer of Example 1 was replaced with R-1, R-2, R-3, R-4, R-5, R-6 and R-7 respectively, and the other steps were the same to obtain comparative organic electroluminescent devices 1 to 7.
[0380]
[0381] The test results of the luminescent characteristics of the organic electroluminescent devices prepared in Examples 1 to 33 of the present invention and Comparative Examples 1 to 7 are shown in Table 1.
[0382] Table 1 Test data of luminescence characteristics of organic electroluminescent devices
[0383]
[0384]
[0385]
[0386] It can be seen from Table 1 that, compared with comparative devices 1 to 7, the organic electroluminescent device whose electron transport layer contains the heterocyclic compound of Formula 1 of the present invention has lower driving voltage, higher luminous efficiency and longer service life, and the performance of the device is more excellent.
[0387] Example 34: Preparation of organic electroluminescent device 34
[0388] HI-1 and HT-2 were vacuum-deposited on the ITO anode, and the two formed a hole injection layer with a ratio of HI-1:HT-2=5:95 (wt%), and the thickness was 10nm; HT-2 was vacuum-deposited on the hole injection layer as a hole transport layer with a thickness of 110nm; EB-1 was vacuum-deposited on the hole transport layer as an electron blocking layer with a thickness of 35nm; GH-3 and GH-2 were vacuum-deposited on the electron blocking layer as the main material in a ratio of 1:1 (wt%), and the doping material GD-1 was based on The main material and the doping material are doped in an amount of 8wt% of the total amount to form a light-emitting layer with a thickness of 25nm; the compound 13 of the present invention is vacuum evaporated on the light-emitting layer as a hole blocking layer with a thickness of 15nm; ET-1:LiQ=1:1 (wt%) is vacuum evaporated on the hole blocking layer as an electron transport layer with a thickness of 28nm; LiF is vacuum evaporated on the electron transport layer as an electron injection layer with a thickness of 1.0nm; Al is vacuum evaporated on the electron injection layer as a cathode with a thickness of 110nm.
[0389] Examples 35-60: Preparation of organic electroluminescent devices 35-60
[0390] The compound 13 in the hole blocking layer of Example 34 is replaced by compound 27, compound 33, compound 52, compound 86, compound 101, compound 107, compound 137, compound 159, compound 163, compound 189, compound 303, compound 391, compound 394, compound 401, compound 414, compound 475, compound 666, compound 679, compound 685, compound 695, compound 798, compound 848, compound 893, compound 966, compound 972, and compound 976, respectively, and the other steps are the same to obtain organic electroluminescent devices 35 to 60.
[0391] Comparative Examples 8 to 12: Preparation of Comparative Organic Electroluminescent Devices 8 to 12
[0392] The compound 13 in the hole blocking layer of Example 34 was replaced with R-8, R-9, R-10, R-11 and R-7 respectively, and the other steps were the same to obtain comparative organic electroluminescent devices 8 to 12.
[0393]
[0394]
[0395] The test results of the luminescent characteristics of the organic electroluminescent devices prepared in Examples 34 to 60 of the present invention and Comparative Examples 8 to 12 are shown in Table 2.
[0396] Table 2 Test data of luminescence characteristics of organic electroluminescent devices
[0397]
[0398]
[0399] It can be seen from Table 2 that the organic electroluminescent device containing the heterocyclic compound of Formula 1 of the present invention in the hole blocking layer has a lower driving voltage, a higher luminous efficiency and a longer service life than the comparative device.
[0400] Example 61: Preparation of organic electroluminescent device 61
[0401] HI-1 and HI-2 were vacuum-deposited on the ITO anode, and the two formed a hole injection layer with a ratio of HI-1:HI-2=5:95 (wt%), with a thickness of 10 nm; HT-1 was vacuum-deposited on the hole injection layer as a hole transport layer 1 with a thickness of 50 nm; BH-1 and BD-1 were vacuum-deposited on the hole transport layer 1, and the two were doped with a ratio of BH-1:BD-1=95:5 (wt%) to form a light-emitting layer 1 with a thickness of 30 nm; ET-1 was vacuum-deposited on the light-emitting layer as an electron transport layer 1 with a thickness of 25 nm; Compound 13 of the present invention and Li were vacuum-deposited on the electron transport layer 1, and the two were doped with a ratio of Compound 13 of the present invention and Li=97:3 (wt%) to form an N-type charge generation layer with a thickness of 10 nm; HT-3 and HI-4 are vacuum evaporated on the N-type charge generation layer, and the two are doped in the ratio of HT-3:HI-4=90:10 (wt%) to form a P-type charge generation layer with a thickness of 10nm; HT-4 is vacuum evaporated on the P-type charge generation layer to form a hole transport layer 2 with a thickness of 30nm; BH-1 and BD-1 are vacuum evaporated on the hole transport layer 2, and the two are doped in the ratio of BH-1:BD-1=95:5 (wt%) to form a light-emitting layer 2 with a thickness of 30nm; Alq3 is vacuum evaporated on the light-emitting layer 2 to form an electron transport layer 2 with a thickness of 10nm; LiF is vacuum evaporated on the electron transport layer 2 as an electron injection layer with a thickness of 1.0nm; Al is vacuum evaporated on the electron injection layer as a cathode with a thickness of 110nm.
[0402]
[0403] Examples 62 to 82: Preparation of organic electroluminescent devices 62 to 82
[0404] The N-type charge generation layer compound 13 in Example 61 is replaced by compound 27, compound 33, compound 52, compound 107, compound 137, compound 163, compound 189, compound 303, compound 349, compound 391, compound 401, compound 414, compound 666, compound 685, compound 695, compound 793, compound 798, compound 848, compound 861, compound 893, and compound 895, respectively, and the other steps are the same to obtain organic electroluminescent devices 62 to 82.
[0405] Comparative Examples 13-14: Preparation of Comparative Organic Electroluminescent Devices 13-14
[0406] The N-type charge generation layer compound 13 in Example 61 was replaced by R-12 and R-13 respectively, and the other steps were the same to obtain comparative organic electroluminescent devices 13 to 14.
[0407] The test results of the luminescent characteristics of the organic electroluminescent devices prepared in Examples 61 to 82 of the present invention and Comparative Examples 13 to 14 are shown in Table 3.
[0408] Table 3 Test data of luminescence characteristics of organic electroluminescent devices
[0409]
[0410] It can be seen from Table 3 that when the heterocyclic compound of Formula 1 of the present invention is used as an N-type charge generation layer material in an organic electroluminescent device, the device has higher luminous efficiency and longer service life than the control device, and the compound of the present invention is an N-type charge generation layer material with excellent performance.
[0411] It should be noted that the present invention is particularly described using individual embodiments. However, without departing from the principles of the present invention, a person skilled in the art may make various improvements in form or detail to the present invention, and these improvements also fall within the scope of protection of the present invention.
Claims
1. A heterocyclic compound, characterized in that It is represented by the following formula 1: Wherein, the x is the same or different and is selected from CR c or N, and at least one x is selected from N, at most three x are selected from N, and the x bonded to L0, L1, L2 is selected from C atoms; The R c One selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring; The Ar1 is selected from the group shown in the following formula 1-a or formula 1-b, The Y is selected from O or S; the z is the same or different and is selected from CR0 or N, and the z bonded to L1 is selected from C atom; The R0 is selected from one of hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring; The R1 is selected from one of hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring; The R a , R b the same or different selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring; the "substituted or unsubstituted C2-C30 heteroaryl" is selected from substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted triazine, substituted or unsubstituted quinolyl, substituted or unsubstituted isoquinolyl, substituted or unsubstituted quinazolinyl, substituted or unsubstituted quinoxalinyl, substituted or unsubstituted o-phenanthroline, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted benzoxazolyl, substituted or unsubstituted benzothiazolyl; or said R a , R b The corresponding C atom is the connection site with L2, or the adjacent R a , R b Bonded to form one of the following alicyclic or spirocyclic structures, The R q The same or different ones are selected from hydrogen, deuterium, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring; The R2 and R3 are the same or different and are selected from one of hydrogen, deuterium, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring, or two adjacent R3 are bonded to form a substituted or unsubstituted ring; the "substituted or unsubstituted" substituent is selected from one of hydrogen, deuterium, halogen, C1-C30 alkyl, C3-C30 cycloalkyl, C6-C30 aryl, C2-C30 heteroaryl, C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring; The n1 is selected from 0, 1, 2 or 3; the n2 is selected from 0, 1, 2, 3 or 4; The q1 is selected from 0, 1, 2, 3 or 4; the q2 is selected from 0, 1, 2, 3, 4, 5 or 6; the q3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the q4 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; the q5 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12; the q6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14; the q7 is selected from 0, 1 or 2; The Ar is selected from one of the formula 1-a, formula 1-b or the groups shown below, The v is the same or different from CR d or N, and v bonded to L0 is selected from C atoms; The W is selected from O, S, CR f R g or NR h ; The R d the same or different selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or two adjacent R d Bonding to form substituted or unsubstituted alicyclic or aromatic rings; The R f , R g The same or different R is selected from hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or adjacent R f , R g Bonding to form a substituted or unsubstituted ring; The R h One selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring; The L2 is selected from one or a combination of the following groups d-1 to d-6, The t is the same or different from CR i or N; The Q1 is selected from O, S, CR j R k or NR m ; Q2 is selected from O or S; The R i The same or different R is selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or two adjacent R i Bonding to form a substituted or unsubstituted ring; The R j , R k The same or different R is selected from hydrogen, deuterium, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 alicyclic and C6-C30 aromatic fused ring, or adjacent R j , R k Bonding to form a substituted or unsubstituted ring; The R m One selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, and a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring; The L0 and L1 are the same or different and are selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, a substituted or unsubstituted C3-C30 alicyclic ring and a C6-C30 aromatic ring fused sub-group; The "substituted or unsubstituted" substituent group in L0 and L1 is selected from one of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted silyl, substituted or unsubstituted C3-C30 cycloalkyl, and substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring; The condition is that the R a , R b When the corresponding C atom is the connection site with L2, the case where L2 is selected from the group shown in d-1 is excluded.
2. The heterocyclic compound according to claim 1, characterized in that The formula 1-a is selected from one of the following groups: The formula 1-b is selected from one of the following groups: Said Y is selected from O or S; The R0 is selected from hydrogen, deuterium or a substituted or unsubstituted group as shown below: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tritert-butyl, ... Butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl; The R1 is selected from hydrogen, deuterium or a substituted or unsubstituted group as shown below: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tritert-butyl, ... Butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl; The m1 is selected from 0, 1, 2 or 3; the m2 is selected from 0, 1 or 2; the m3 is selected from 0 or 1; and the m4 is selected from 0, 1, 2, 3 or 4.
3. The heterocyclic compound according to claim 1, characterized in that Said One selected from the following groups, The R4 and R5 are the same or different and are selected from hydrogen, deuterium or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl , triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl; The R2 and R3 are the same or different and are selected from hydrogen, deuterium, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, or two adjacent R3 may be bonded to each other to form a substituted or unsubstituted ring; The R q the same or different ones are selected from one or a combination of hydrogen, deuterium, tritium, halogen, methyl, ethyl, propyl, butyl, trifluoromethyl, isopropyl, cyclopropyl, tert-butyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, trimethylsilyl, triethylsilyl, triphenylsilyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthryl, triphenylene, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl; The q1 is selected from 0, 1, 2, 3 or 4; the q2 is selected from 0, 1, 2, 3, 4, 5 or 6; the q3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the q4 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; the q6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14; The n1 is selected from 0, 1, 2 or 3; the n2 is selected from 0, 1, 2, 3 or 4; the n3 is selected from 0, 1, 2, 3, 4 or 5; the n4 is selected from 0, 1, 2, 3, 4, 5, 6 or 7; and n5 is selected from 0, 1, 2, 3, 4, 5 or 6.
4. The heterocyclic compound according to claim 1, characterized in that The Ar is selected from one of the formula 1-a, formula 1-b or the groups shown below, The W is selected from O, S, CR f R g or NR h ; The R d the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups substituted or unsubstituted by one or more deuterium, C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl alkyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, dibenzofuranyl, dibenzothienyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, or two adjacent R d Bonding to form substituted or unsubstituted benzene rings; The R f , R g The same or different ones are selected from hydrogen, deuterium or one or more deuterium, C1-C6 alkyl substituted or unsubstituted one of the following groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylmethyl Silyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, or an adjacent R f , R g Bonding to form a substituted or unsubstituted ring; The R h One of the following groups substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilane yl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropyl, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl; The R e the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuteriums or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl; The p1 is selected from 0, 1, 2, 3, 4 or 5; the p2 is selected from 0, 1, 2, 3 or 4; the p3 is selected from 0, 1, 2 or 3; the p4 is selected from 0, 1, 2, 3, 4, 5, 6 or 7; the p5 is selected from 0, 1, 2, 3, 4, 5 or 6; the p6 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8 or 9; the p7 is selected from 0, 1 or 2; the p8 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the p9 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11.
5. The heterocyclic compound according to claim 1, characterized in that The L2 is selected from one or a combination of the following groups: The R i the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, or two adjacent R i Bonding to form a substituted or unsubstituted ring; The R j , R k The same or different ones are selected from hydrogen, deuterium or one or more deuterium, C1-C6 alkyl substituted or unsubstituted one of the following groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, triphenylene, trimethylsilyl, triethylsilane one of benzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl and quinoxalinyl; The R m One of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthryl, triphenylene, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, triazine, quinolyl, isoquinolyl, quinazolinyl, and quinoxalinyl; The R s The same or different ones are selected from one or a combination of hydrogen, deuterium, cyano, halogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, naphthyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, and quinoxalinyl; Said c1 is selected from 0, 1, 2, 3 or 4; said c2 is selected from 0, 1, 2, 3, 4, 5 or 6; said c3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; said c4 is selected from 0, 1, 2 or 3; said c5 is selected from 0, 1 or 2; said c6 is selected from 0 or 1; said c7 is selected from 0, 1, 2, 3, 4 or 5; said c8 is selected from 0, 1, 2, 3, 4, 5, 6 or 7; The s1 is selected from 0, 1 or 2; the s2 is selected from 0, 1, 2, 3 or 4; the s3 is selected from 0, 1, 2, 3, 4, 5 or 6; the s4 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8.
6. The heterocyclic compound according to claim 1, characterized in that The L0 and L1 are the same or different and are selected from a single bond, or one or a combination of the following groups: The R t the same or different selected from hydrogen, deuterium, cyano, halogen or one of the following groups which are substituted or unsubstituted by one or more deuterium or C1-C6 alkyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri-tert-butylsilyl, triphenylsilyl, ethyldimethylsilyl, tert-butyldimethylsilyl, benzocyclopropane, benzocyclobutane, benzocyclopentane, benzocyclohexane, benzocycloheptane, benzocyclopentenyl, benzocyclohexenyl, or two adjacent R t Bonding to form a substituted or unsubstituted ring; The e1 is selected from 0, 1, 2, 3 or 4; the e2 is selected from 0, 1, 2, 3, 4, 5 or 6; the e3 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; the e4 is selected from 0, 1, 2 or 3; the e5 is selected from 0, 1 or 2; the e6 is selected from 0 or 1; the e7 is selected from 0, 1, 2, 3, 4 or 5; the e8 is selected from 0, 1, 2, 3, 4, 5, 6 or 7.
7. The heterocyclic compound according to claim 1, characterized in that The heterocyclic compound is selected from any one of the following structures:
8. An organic electroluminescent device, characterized in that: The organic electroluminescent device comprises a first electrode; a second electrode arranged opposite to the first electrode; and an organic layer arranged between the first electrode and the second electrode, wherein the organic layer contains the heterocyclic compound according to any one of claims 1 to 7.
9. The organic electroluminescent device according to claim 8, characterized in that: The organic layer includes at least one of a hole transport region, a light emitting layer, and an electron transport region, and at least one of the electron transport region and the light emitting layer contains the heterocyclic compound according to any one of claims 1 to 7.
10. The organic electroluminescent device according to claim 8, characterized in that: The organic layer is located between the first electrode and the second electrode, the organic layer includes a first stack that emits light of a first color and a second stack that emits light of a second color, and a charge generation layer located between the first stack and the second stack, the charge generation layer includes an N-type charge generation layer arranged adjacent to the first stack and a P-type charge generation layer arranged adjacent to the second stack, and the N-type charge generation layer contains the heterocyclic compound described in any one of claims 1 to 7.
Citation Information
Cited By
Triazine compound, OLED (Organic Light Emitting Diode) with same and organic light emitting device
CN119143687A
A triazine compound, an OLED having the same, and an organic light-emitting device
CN119143687B
Triazinyl compound, OLED (Organic Light Emitting Diode) with same and organic light emitting device
CN122010856A
Triazine compound, and OLED and organic light-emitting device comprising same
WO2026103247A1
Triazine compound, and organic electroluminescent element, electronic device, and electronic element using said compound
WO2026105801A1
